S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I. (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I. (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I. (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I. (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
NYSE:QGEN

Qiagen (QGEN) Earnings Date, Estimates & Call Transcripts

$45.29
-0.15 (-0.33%)
(As of 06/9/2023 ET)
Compare
Today's Range
$45.20
▼
$45.58
50-Day Range
$43.93
▼
$46.76
52-Week Range
$40.38
▼
$51.18
Volume
639,633 shs
Average Volume
835,638 shs
Market Capitalization
$10.31 billion
P/E Ratio
29.41
Dividend Yield
N/A
Price Target
$54.87
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Jul. 25Estimated
Actual EPS
(May. 3)
$0.51 Beat By $0.04
Consensus EPS
(May. 3)
$0.47
Last Year's Q2 EPS
(4/26/2022)
$0.80
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

QGEN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

QGEN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Qiagen Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20232$0.46$0.47$0.47 
Q2 20232$0.49$0.51$0.50 
Q3 20232$0.54$0.54$0.54 
Q4 20232$0.59$0.60$0.60 
FY 20238$2.08$2.12$2.10 
Q1 20242$0.51$0.53$0.52 
Q2 20242$0.51$0.54$0.53 
Q3 20242$0.55$0.56$0.56 
Q4 20242$0.58$0.63$0.61 
FY 20248$2.15$2.26 $2.21

QGEN Earnings Date and Information

Qiagen last released its earnings data on May 3rd, 2023. The reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.04. The business had revenue of $485.40 million for the quarter, compared to the consensus estimate of $478.23 million. Its quarterly revenue was down 22.8% compared to the same quarter last year. Qiagen has generated $1.54 earnings per share over the last year ($1.54 diluted earnings per share) and currently has a price-to-earnings ratio of 29.4. Earnings for Qiagen are expected to grow by 7.55% in the coming year, from $2.12 to $2.28 per share. Qiagen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 25th, 2023 based off prior year's report dates.

Qiagen Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
7/25/2023
(Estimated)		        
5/3/2023Q1 23$0.47$0.51+$0.04$0.65$478.23 million$485.40 million  
2/7/2023Q4 22$0.47$0.53+$0.06$0.67$486.93 million$531.00 million    
11/7/2022Q3 2022$0.45$0.53+$0.08$0.70$479.99 million$499.63 million
7/26/2022Q2 2022$0.45$0.51+$0.06$0.60$498.09 million$515.51 million
4/26/2022Q1 2022$0.71$0.80+$0.09$0.93$589.95 million$628.39 million
4/26/2022Q1 2022$0.71$0.80+$0.09$0.93$589.95 million$628.39 million    
2/8/2022Q4 2021$0.60$0.74+$0.14$0.92$531.52 million$582.40 million
2/8/2022Q4 2021$0.60$0.74+$0.14$0.92$535.47 million$582.40 million    
11/3/2021Q3 2021$0.53$0.58+$0.05$0.59$487.35 million$534.75 million
11/3/20219/30/2021$0.53$0.58+$0.05$0.59$487.35 million$534.75 million    
7/29/2021Q2 2021$0.66$0.67+$0.01$0.82$562.35 million$567.31 million
7/29/20216/30/2021$0.66$0.67+$0.01$0.82$562.35 million$567.31 million    
5/3/2021Q1 2021$0.63$0.66+$0.03$0.76$555.33 million$567.21 million
5/2/20213/31/2021$0.63$0.66+$0.03$0.76$557.57 million$567.21 million  
2/9/2021Q4 2020$0.66$0.68+$0.02$0.45$551.85 million$571.23 million
2/9/202112/31/2020$0.66$0.68+$0.02$0.45$551.85 million$571.23 million  
10/27/2020Q3 2020$0.54$0.58+$0.04$1.09$449.50 million$483.76 million
10/27/20209/30/2020$0.56$0.58+$0.02$1.09$449.50 million$483.76 million  
8/4/2020Q2 2020$0.55$0.55$0.72$443.00 million$443.25 million
8/4/20206/30/2020$0.55$0.55$0.72$441.80 million$443.30 million
5/6/2020Q1 2020$0.35$0.34($0.01)$0.51$372.10 million
5/6/20203/31/2020$0.27$0.34+$0.07$0.51$342.71 million$372.10 million
2/4/2020Q4 2019$0.44$0.48+$0.04$0.77$408.89 million$413.47 million
2/4/202012/31/2019$0.44$0.48+$0.04$0.77$408.28 million$413.50 million  
10/30/2019Q3 2019$0.35$0.36+$0.01$1.43$383.69 million$382.69 million
10/30/2019Q3$0.35$0.36+$0.01$1.43$382.98 million$382.70 million  
7/24/2019Q2 2019$0.34$0.33($0.01)$0.47$386.37 million$381.60 million
7/24/2019Q2 2019$0.34$0.33($0.01)$0.47$386.37 million$381.60 million
5/6/2019Q1 2019$0.26$0.27+$0.01$0.41$351.33 million$348.65 million
5/6/20193/31/2019$0.26$0.27+$0.01$0.41$351.68 million$348.70 million
2/4/2019Q4 2018$0.40$0.40$0.54$409.01 million$403.17 million
2/4/201912/31/2018$0.40$0.40$0.54$409.32 million$403.20 million  
10/29/2018Q3 2018$0.33$0.35+$0.02$0.44$382.16 million$377.91 million
10/29/2018Q3 2018$0.33$0.35+$0.02$0.44$382.16 million$377.91 million
10/29/20189/30/2018$0.33$0.35+$0.02$0.44$380.11 million$377.90 million
7/31/2018Q2 2018$0.32$0.33+$0.01$0.50$376.89 million$377.20 million
7/31/2018Q2 2018$0.32$0.33+$0.01$0.50$376.89 million$377.20 million
7/31/20186/30/2018$0.32$0.33+$0.01$0.50$376.89 million$377.20 million
5/2/2018Q1 2018$0.24$0.26+$0.02$0.38$340.10 million$343.57 million
5/2/2018Q1 2018$0.24$0.26+$0.02$0.38$340.10 million$343.57 million
5/2/20183/31/2018$0.24$0.26+$0.02$0.38$339.30 million$343.60 million
1/31/2018Q4 2017$0.42$0.43+$0.01$1.04$394.48 million$396.86 million
1/31/2018Q4 2017$0.42$0.43+$0.01$1.04$394.48 million$396.86 million
1/31/2018Q4 2017$0.42$0.43+$0.01$1.04$394.48 million$396.86 million
11/6/2017Q3 2017$0.32$0.32$0.43$365.10 million$363.98 million
11/6/2017Q3 2017$0.32$0.32$0.43$365.10 million$363.98 million
11/6/2017Q3$0.32$0.32$0.43$363.42 million$364.00 million
7/27/2017Q2 2017$0.29$0.30+$0.01$0.54$347.27 million$349.00 million
7/27/2017Q2 2017$0.29$0.30+$0.01$0.54$347.27 million$349.00 million
7/27/20176/30/2017$0.28$0.30+$0.02$0.54$353.09 million$349.00 million
5/2/2017Q1 2017$0.21$0.22+$0.01$0.36$307.14 million$307.71 million
5/2/2017Q1 2017$0.21$0.22+$0.01$0.36$307.14 million$307.71 million
5/2/2017Q1 2017$0.21$0.22+$0.01$0.36$307.14 million$307.71 million
2/1/2017Q4 2016$0.39$0.39$0.74$371.89 million$366.50 million
2/1/2017Q4 2016$0.39$0.39$0.74$371.89 million$366.50 million
2/1/2017Q4 2016$0.39$0.39$0.74$372.70 million$366.50 million  
11/2/2016Q3 2016$0.28$0.30+$0.02$0.45$337.79 million$338.70 million
11/2/2016Q3 2016$0.28$0.30+$0.02$0.45$337.79 million$338.70 million
11/2/2016Q3 2016$0.28$0.30+$0.02$0.45$335.46 million$338.70 million
7/28/2016Q2 2016$0.24$0.25+$0.01$0.41$327.85 million$334.40 million
7/28/2016Q2 2016$0.24$0.25+$0.01$0.41$327.85 million$334.40 million
7/28/2016Q2 2016$0.24$0.25+$0.01$0.41$326.73 million$334.40 million
4/27/2016Q1 2016$0.20$0.20$0.34$294.89 million$298.38 million
4/27/2016Q1 2016$0.20$0.20$0.34$294.89 million$298.38 million
4/27/2016Q1 2016$0.20$0.20$0.34$295.76 million$298.40 million
2/2/2016Q415$0.32$0.33+$0.01$354.47 million$349.00 million
1/2/2016Q4 2015$0.32$0.32$0.43$350.40 million$348.54 million
1/2/2016Q4 2015$0.32$0.32$0.43$350.40 million$348.54 million
1/2/2016Q4 2015$0.32$0.32$0.43$350.40 million$348.54 million
10/28/2015Q3 2015$0.29$0.28($0.01)$0.41$324.35 million$314.60 million
10/28/2015Q3 2015$0.29$0.28($0.01)$0.41$324.35 million$314.60 million
10/28/2015Q3 2015$0.29$0.28($0.01)$0.41$323.50 million$314.60 million  
7/29/2015Q2 2015$0.26$0.27+$0.01$0.43$317.22 million$319.46 million
7/29/2015Q2 2015$0.26$0.27+$0.01$0.43$317.22 million$319.46 million
7/29/2015Q2 2015$0.26$0.27+$0.01$0.43$319.43 million$319.50 million  
5/5/2015Q1 2015$0.23$0.23$0.38$304.31 million$298.43 million
5/5/2015Q1 2015$0.23$0.23$0.38$304.31 million$298.43 million
5/5/2015Q1 2015$0.23$0.23$0.38$304.60 million$298.70 million
1/28/2015Q4 2014$0.31$0.26($0.05)$0.41$367.32 million$360.41 million
1/28/2015Q4 2014$0.31$0.26($0.05)$0.41$367.32 million$360.41 million
1/28/2015Q4 2014$0.31$0.26($0.05)$0.41$367.82 million$360.80 million
10/29/2014Q3 2014$0.28$0.28$0.41$336.86 million$336.46 million
10/29/2014Q3 2014$0.28$0.28$0.41$336.86 million$336.46 million
10/29/2014Q3 2014$0.28$0.28$0.41$337.00 million$336.80 million
7/29/2014Q2 2014$0.26$0.26$0.37$330.28 million$330.84 million
7/29/2014Q2 2014$0.26$0.26$0.37$330.28 million$330.84 million
7/29/2014Q2 2014$0.26$0.26$0.37$330.76 million$331.20 million
5/6/2014Q1 2014$0.23$0.23$0.36$318.64 million$317.07 million
5/6/2014Q1 2014$0.23$0.23$0.36$318.64 million$317.07 million
5/6/2014Q1 2014$0.23$0.23$0.36$317.09 million$317.40 million
1/29/2014Q4 2013$0.34$0.34$0.42$363.75 million$361.09 million
1/29/2014Q4 2013$0.34$0.34$0.42$363.75 million$361.09 million
1/29/2014Q4 2013$0.34$0.34$0.42$365.52 million$362.60 million
10/29/2013Q3 2013$0.26$0.27+$0.01$0.36$320.10 million$322.11 million
10/29/2013Q3 2013$0.26$0.27+$0.01$0.36$320.10 million$322.11 million
10/29/2013Q3 2013$0.26$0.27+$0.01$0.36$320.37 million$323.80 million  
7/30/2013Q2 2013$0.24$0.25+$0.01$0.73$312.04 million$315.21 million
7/30/2013Q2 2013$0.24$0.25+$0.01$0.73$312.04 million$315.21 million
7/30/2013Q2 2013$0.24$0.25+$0.01$0.73$311.75 million$316.40 million  
4/29/2013Q1 2013$0.23$0.21($0.02)$0.34$306.10 million$303.58 million
4/29/2013Q1 2013$0.23$0.21($0.02)$0.34$306.10 million$303.58 million
4/29/2013Q1 2013$0.23$0.21($0.02)$0.34$305.50 million$303.60 million
1/29/2013Q412$0.31$0.34+$0.03$327.80 million$346.50 million  
11/5/2012Q312$0.24$0.26+$0.02$303.79 million$304.30 million
7/24/2012$0.25$0.25
4/25/2012$0.21$0.23+$0.02
1/31/2012$0.28$0.31+$0.03
11/2/2011$0.22$0.24+$0.02  
7/25/2011$0.23$0.23
4/27/2011$0.21$0.21
1/31/2011$0.25$0.26+$0.01
11/8/2010Q3 2010$0.24$0.25+$0.01$0.34
8/9/2010Q2 2010$0.22$0.21($0.01)$0.25
5/3/2010Q1 2010$0.20$0.21+$0.01$0.27
2/8/2010Q4 2009$0.23$0.25+$0.02$0.31
11/9/2009Q3 2009$0.24$0.26+$0.02$0.33
8/10/2009Q2 2009$0.22$0.24+$0.02$0.32
5/4/2009Q1 2009$0.20$0.20$0.27
2/9/2009Q4 2008$0.22$0.21($0.01)$0.29
11/11/2008Q3 2008$0.20$0.22+$0.02$0.33
8/4/2008Q2 2008$0.20$0.21+$0.01$0.30
5/5/2008Q1 2008$0.16$0.19+$0.03$0.28
2/11/2008Q4 2007$0.15$0.17+$0.02$0.27












Qiagen Earnings - Frequently Asked Questions

When is Qiagen's earnings date?

Qiagen has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 25th, 2023 based off last year's report dates. Learn more on QGEN's earnings history.

Did Qiagen beat their earnings estimates last quarter?

In the previous quarter, Qiagen (NYSE:QGEN) reported $0.51 earnings per share (EPS) to beat the analysts' consensus estimate of $0.47 by $0.04. Learn more on analysts' earnings estimate vs. QGEN's actual earnings.

How can I listen to Qiagen's earnings conference call?

The conference call for Qiagen's latest earnings report can be listened to online. Listen to Conference Call

How much revenue does Qiagen generate each year?

Qiagen (NYSE:QGEN) has a recorded annual revenue of $2.14 billion.

How much profit does Qiagen generate each year?

Qiagen (NYSE:QGEN) has a recorded net income of $423.21 million. QGEN has generated $1.54 earnings per share over the last four quarters.

What is Qiagen's price-to-earnings ratio?

Qiagen (NYSE:QGEN) has a trailing price-to-earnings ratio of 29.41 and a forward price-to-earnings ratio of 21.36. The price/earnings-to-growth ratio is 8.29.

What is Qiagen's EPS forecast for next year?

Qiagen's earnings are expected to grow from $2.12 per share to $2.28 per share in the next year, which is a 7.55% increase.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:QGEN) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -